MVP and cardiomyopathy: Adeno-associated virus serotype 9 (AAV9)-mediated overexpression of MVP significantly attenuates cardiomyocyte apoptosis in DiCM through activating AKT, providing a potential cardioprotective target to improve cardiac function from DOX-induced cardiomyopathy.